Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow stem cells in end-stage liver disease
ChiCTR-ONC-12002103Phase 2Completed
- Sponsor
- The 105st Hospital of PLA
- Start
- Feb 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow stem cells in hepatic disease and Cirrhosis, sponsored by The 105st Hospital of PLA. Primary endpoints: Death, Total bilirubin, alanine aminotransferase, aspartate aminotransferase and 1 more. Started Feb 2012; status: completed.
02
Drugs
autologous bone marrow stem cells
03
Conditions
hepatic diseaseCirrhosis
Beyond the preview
Go deeper on ChiCTR-ONC-12002103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002103.